250 related articles for article (PubMed ID: 28821814)
1. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.
Fang D; Shi D; Lv L; Gu S; Wu W; Chen Y; Guo J; Li A; Hu X; Guo F; Ye J; Li Y; Li L
Sci Rep; 2017 Aug; 7(1):8770. PubMed ID: 28821814
[TBL] [Abstract][Full Text] [Related]
2. Vital members in the gut microbiotas altered by two probiotic Bifidobacterium strains against liver damage in rats.
Zha H; Fang DQ; van der Reis A; Chang K; Yang LY; Xie JJ; Shi D; Xu QM; Li YT; Li LJ
BMC Microbiol; 2020 Jun; 20(1):144. PubMed ID: 32503418
[TBL] [Abstract][Full Text] [Related]
3. Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two
Zha H; Li Q; Chang K; Xia J; Li S; Tang R; Li L
Front Immunol; 2022; 13():791152. PubMed ID: 35401547
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the intestinal bacterial microbiota profiles in Bifidobacterium pseudocatenulatum LI09 pre-treated rats with D-galactosamine-induced liver injury.
Zha H; Xia J; Si G; Tang R; Li S; Li Q; Lou Y; Wo W; Chang K; Li L
World J Microbiol Biotechnol; 2022 Dec; 39(2):43. PubMed ID: 36520300
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats.
Li Y; Lv L; Ye J; Fang D; Shi D; Wu W; Wang Q; Wu J; Yang L; Bian X; Jiang X; Jiang H; Yan R; Peng C; Li L
Appl Microbiol Biotechnol; 2019 Jan; 103(1):375-393. PubMed ID: 30345482
[TBL] [Abstract][Full Text] [Related]
6. Multiple Intestinal Bacteria Associated with the Better Protective Effect of
Zha H; Si G; Wang C; Zhang H; Li L
Biomed Res Int; 2022; 2022():8647483. PubMed ID: 35127946
[No Abstract] [Full Text] [Related]
7. Characteristics of the gut microbiota in Bifidobacterium catenulatum LI10 pretreated rats with lower levels of D-galactosamine-induced liver damage.
Zha H; Si G; Wang C; Lv J; Zhang H; Li L
J Appl Microbiol; 2022 Aug; 133(2):375-384. PubMed ID: 35365858
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure.
Wang K; Lv L; Yan R; Wang Q; Jiang H; Wu W; Li Y; Ye J; Wu J; Yang L; Bian X; Jiang X; Lu Y; Xie J; Wang Q; Shen J; Li L
mSphere; 2020 Jan; 5(1):. PubMed ID: 31996423
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
Jiang H; Yan R; Wang K; Wang Q; Chen X; Chen L; Li L; Lv L
Biomed Pharmacother; 2021 Jan; 133():111000. PubMed ID: 33202285
[TBL] [Abstract][Full Text] [Related]
10. The synergy of dietary supplements
Zhuge A; Li S; Yuan Y; Li B; Li L
Food Funct; 2021 Oct; 12(20):10239-10252. PubMed ID: 34546256
[No Abstract] [Full Text] [Related]
11. Exopolysaccharides from
Xu R; Aruhan ; Xiu L; Sheng S; Liang Y; Zhang H; Liu Y; Tong H; Du R; Wang X
J Agric Food Chem; 2019 Oct; 67(42):11627-11637. PubMed ID: 31553177
[TBL] [Abstract][Full Text] [Related]
12.
Chen Y; Yang B; Stanton C; Ross RP; Zhao J; Zhang H; Chen W
J Agric Food Chem; 2021 Feb; 69(5):1496-1512. PubMed ID: 33512996
[TBL] [Abstract][Full Text] [Related]
13. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.
Wang Q; Lv L; Jiang H; Wang K; Yan R; Li Y; Ye J; Wu J; Wang Q; Bian X; Yang L; Jiang X; Xie J; Lu Y; Shen J; Li L
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9673-9686. PubMed ID: 31713675
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Genomic Diversity and Antimicrobial Susceptibility of Bifidobacterium pseudocatenulatum in a Vietnamese Population.
Chung The H; Nguyen Ngoc Minh C; Tran Thi Hong C; Nguyen Thi Nguyen T; Pike LJ; Zellmer C; Pham Duc T; Tran TA; Ha Thanh T; Van MP; Thwaites GE; Rabaa MA; Hall LJ; Baker S
Microbiol Spectr; 2021 Oct; 9(2):e0052621. PubMed ID: 34523984
[TBL] [Abstract][Full Text] [Related]
16.
Lv L; Yao C; Yan R; Jiang H; Wang Q; Wang K; Ren S; Jiang S; Xia J; Li S; Yu Y
mSystems; 2021 Jun; 6(3):e0038421. PubMed ID: 34128694
[TBL] [Abstract][Full Text] [Related]
17. Xylan alleviates dietary fiber deprivation-induced dysbiosis by selectively promoting Bifidobacterium pseudocatenulatum in pigs.
Wang Z; Bai Y; Pi Y; Gerrits WJJ; de Vries S; Shang L; Tao S; Zhang S; Han D; Zhu Z; Wang J
Microbiome; 2021 Nov; 9(1):227. PubMed ID: 34802456
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry.
Osman N; Adawi D; Ahrné S; Jeppsson B; Molin G
Dig Liver Dis; 2007 Sep; 39(9):849-56. PubMed ID: 17652039
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis.
Moratalla A; Gómez-Hurtado I; Santacruz A; Moya Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R
Liver Int; 2014 Jul; 34(6):850-8. PubMed ID: 24267920
[TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.
Moya-Pérez A; Neef A; Sanz Y
PLoS One; 2015; 10(7):e0126976. PubMed ID: 26161548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
